Literature DB >> 2453058

Constitutive synthesis of activator protein 1 transcription factor after viral transformation of mouse fibroblasts.

J Piette1, S Hirai, M Yaniv.   

Abstract

Transcription factor activator protein 1 (AP1) interacts with the promoter region of a number of genes that are stimulated by growth factors present in serum or by agents such as phorbol 12-myristate 13-acetate (PMA) that partially mimic their action. To investigate the possible role of AP1 in the control of cellular growth and in transformation of mammalian cells, we monitored its activity by binding to a specific DNA probe in normal or transformed mouse NIH 3T3 cells. A 3- to 4-fold increase in the DNA-binding activity was found after serum stimulation of quiescent NIH 3T3 cells. A 2- to 3-fold activation was found after treatment with PMA or dibutyryl-cAMP, suggesting that different signal-transducing pathways could activate AP1 factor in these cells. PMA stimulation was dependent on new protein synthesis. In contrast to normal cells, a high serum-independent AP1 DNA-binding activity was found in NIH 3T3 cells transformed by simian virus 40. These results suggest that constitutive AP1 synthesis may be a crucial step in cellular transformation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2453058      PMCID: PMC280217          DOI: 10.1073/pnas.85.10.3401

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  Effect of protein synthesis inhibitors on growth factor activation of c-fos, c-myc, and actin gene transcription.

Authors:  M E Greenberg; A L Hermanowski; E B Ziff
Journal:  Mol Cell Biol       Date:  1986-04       Impact factor: 4.272

2.  The c-Ha-ras oncogene and a tumor promoter activate the polyoma virus enhancer.

Authors:  C Wasylyk; J L Imler; J Perez-Mutul; B Wasylyk
Journal:  Cell       Date:  1987-02-13       Impact factor: 41.582

Review 3.  Animal cell cycle.

Authors:  A B Pardee; R Dubrow; J L Hamlin; R F Kletzien
Journal:  Annu Rev Biochem       Date:  1978       Impact factor: 23.643

4.  Equilibria and kinetics of lac repressor-operator interactions by polyacrylamide gel electrophoresis.

Authors:  M Fried; D M Crothers
Journal:  Nucleic Acids Res       Date:  1981-12-11       Impact factor: 16.971

5.  Activation of transcription by two factors that bind promoter and enhancer sequences of the human metallothionein gene and SV40.

Authors:  W Lee; A Haslinger; M Karin; R Tjian
Journal:  Nature       Date:  1987 Jan 22-28       Impact factor: 49.962

6.  A cellular DNA-binding protein that activates eukaryotic transcription and DNA replication.

Authors:  K A Jones; J T Kadonaga; P J Rosenfeld; T J Kelly; R Tjian
Journal:  Cell       Date:  1987-01-16       Impact factor: 41.582

7.  Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters.

Authors:  M Castagna; Y Takai; K Kaibuchi; K Sano; U Kikkawa; Y Nishizuka
Journal:  J Biol Chem       Date:  1982-07-10       Impact factor: 5.157

Review 8.  Forskolin: a unique diterpene activator of cyclic AMP-generating systems.

Authors:  K B Seamon; J W Daly
Journal:  J Cyclic Nucleotide Res       Date:  1981

9.  Enhanced transformation by a simian virus 40 recombinant virus containing a Harvey murine sarcoma virus long terminal repeat.

Authors:  M Kriegler; M Botchan
Journal:  Mol Cell Biol       Date:  1983-03       Impact factor: 4.272

10.  A gel electrophoresis method for quantifying the binding of proteins to specific DNA regions: application to components of the Escherichia coli lactose operon regulatory system.

Authors:  M M Garner; A Revzin
Journal:  Nucleic Acids Res       Date:  1981-07-10       Impact factor: 16.971

View more
  39 in total

1.  Transcriptional activation of the CEF-4/9E3 cytokine gene by pp60v-src.

Authors:  M Dehbi; A Mbiguino; M Beauchemin; G Chatelain; P A Bédard
Journal:  Mol Cell Biol       Date:  1992-04       Impact factor: 4.272

2.  HIT cells secrete β-cell mitogenic factors.

Authors:  B Bréant; A Lieuvin; C Lavergne; J C Marie; G Rosselin
Journal:  Endocrine       Date:  1995-01       Impact factor: 3.633

3.  Analysis of recombinant human tumour necrosis factor-alpha-induced CD4 expression on human eosinophils.

Authors:  M Hossain; Y Okubo; S Horie; M Sekiguchi
Journal:  Immunology       Date:  1996-06       Impact factor: 7.397

4.  Compilation of vertebrate-encoded transcription factors.

Authors:  S Faisst; S Meyer
Journal:  Nucleic Acids Res       Date:  1992-01-11       Impact factor: 16.971

5.  A common trans-acting factor is involved in transcriptional regulation of neurotransmitter genes by cyclic AMP.

Authors:  S E Hyman; M Comb; Y S Lin; J Pearlberg; M R Green; H M Goodman
Journal:  Mol Cell Biol       Date:  1988-10       Impact factor: 4.272

6.  Differential effects of the adenovirus E1A oncogene on members of the AP-1 transcription factor family.

Authors:  H van Dam; R Offringa; I Meijer; B Stein; A M Smits; P Herrlich; J L Bos; A J van der Eb
Journal:  Mol Cell Biol       Date:  1990-11       Impact factor: 4.272

Review 7.  Mechanisms of transcriptional regulation of cellular genes by SV40 large T- and small T-antigens.

Authors:  U Moens; O M Seternes; B Johansen; O P Rekvig
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

8.  Loss of responsiveness of an AP1-related factor, PEBP1, to 12-O-tetradecanoylphorbol-13-acetate after transformation of NIH 3T3 cells by the Ha-ras oncogene.

Authors:  M Satake; T Ibaraki; Y Yamaguchi; Y Ito
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

9.  Two overlapping sequence motifs within the polyomavirus enhancer are independently the targets of stimulation by both the tumor promoter 12-O-tetradecanoylphorbol-13-acetate and the Ha-ras oncogene.

Authors:  Y Yamaguchi; M Satake; Y Ito
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

10.  Interaction of nuclear factor EF-1A with the polyomavirus enhancer region.

Authors:  G M Bolwig; P Hearing
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.